Kraig Biocraft Laboratories Inc (KBLB)

[saintcalvus]

Even worse! So, a publicly traded company feels it's a wise use of stock to pay for IR tied to pump newsletters that almost always are associated with companies that implode but not to take advantage of this great, free resource? Does that not show a lack of judgement?

Now lets reword that to more closely reflect the truth.

So, a publicly traded company knows it's best option at this point in it's growth is to use it's own stock to pay for vital Investor Relations using stock promotion firms. Being a risky start-up, it's options are limited and only certain investment firms will take that risk. These investment firms of course have past and present clients that haven't done so well, but that is no fault of the investors in these companies because along with much needed cash, they also provided public exposure of the merits of it's clients company and had a financial interest in the success of their clients. Obtaining adequate financing at the best possible terms is one of the most important goals of a start-up and given that, Kraig Biocraft has successfully accomplished that goal at minimum cost to the company and it's shareholders. This reflects positively on the CEO, Kim Thompson in his ability to navigate this company to future success.